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INTRODUCTION 28
Gammaherpesviruses (γHVs) are large, lymphotropic viruses that establish a life-long infection in their 29 hosts, with long-term latency in lymphocytes (1, 2) . The γHVs include the human pathogens, Epstein-Barr virus 30 (EBV) and Kaposi's sarcoma-associated herpesvirus , and murine gammaherpesvirus 68 31 (γHV68 or MHV-68; ICTV nomenclature Murid herpesvirus 4, MuHV-4) (3). These viruses establish a primary 32 lytic infection in their host that is followed by a prolonged quiescent infection termed latency. Latency is 33 maintained in healthy individuals by a homeostatic relationship between the virus and the host immune response; 34 if this balance is disrupted (e.g., by immunosuppression), γHVs can reactivate from latency and actively replicate. 35
Disruption between the balance of γHV infection and host immune control is associated with HV multiple 36 pathologies, including a range of malignancies (4). 37
The γHVs contain several types of non-coding (nc) RNAs, including nuclear ncRNAs and functional 38 miRNAs; these diverse RNAs including ncRNAs transcribed by RNA polymerase II (e.g. the KSHV PAN RNA 39 and the KSHV and EBV miRNAs) or by RNA pol III (e.g. the EBV-encoded small RNAs (EBERs) and the HV68 40 tRNA-miRNA-encoded RNAs (TMERs)) (5-13). Viral ncRNAs are considered to have important host-modulatory 41 functions, interacting with host proteins and regulating host and viral gene expression. For example, the EBV 42
EBERs are highly expressed during latency, and were discovered through their interaction with the host lupus-43 associated antigen (La) protein, which putatively mediates EBER interaction with TLR3 (14-17).The EBERs have 44 further been shown to interact with several host proteins including ribosomal protein L22, protein kinase R (PKR), 45 and retinoic-acid inducible gene I (RIG-I) (18). These interactions can trigger sustained host innate immune 46 responses that are implicated in the development of EBV-associated malignancies (16, (19) (20) (21) . γHV68, a highly 47 tractable small animal model of HV infection, also encodes several pol III-transcribed ncRNAs known as the 48 tRNA-miRNA-encoded RNAs (TMERs) (22, 23) . The TMERs are dispensable for lytic replication and 49 establishment of latency; however, these transcripts are required for pathogenesis during acute infection of an 50 immunocompromised host (7, (24) (25) (26) . The TMERs contain bi-functional elements with a tRNA-like structure on 51 the 5' end and hairpin loops that are processed into biologically-active miRNAs (7), capable of targeting a number 52 of RNAs for post-transcriptional regulation (27) . Our lab has previously shown that the tRNA-like structure is 53 sufficient to rescue pathogenesis of a TMER deficient viral recombinant, suggesting that like the EBERs, the 54
TMERs may contribute to pathogenesis through their interactions with host proteins (26). Though TMER-host 55 protein interactions have yet to be fully explored, it is notable that several characteristics of the EBERs, such as 56 a 5'-triphosphate and 3'-polyU, are imparted by RNA polymerase III (pol III) transcription (28).These motifs can 57 be recognized by host RNA-binding proteins, such as RIG-I or La, to trigger an innate immune response (16, 20, 58 28, 29) . 59
Pol III is often considered to perform "house-keeping" functions, as it transcribes host genes required for 60 cell growth and maintenance (e.g. U6 snRNA, tRNAs, and 5S rRNA) (30) . Despite this, it is clear that the HVs 61 γHV68 infection activates pol III-dependent promoters 4 can usurp pol III-dependent transcription mechanisms for their own purposes. Latent EBV infection has been 62 shown to upregulate components of pol III and ultimately increase the expression of host pol III transcripts -63 particularly vault RNAsthat allow increased establishment of viral infection and gene expression (31) (32) (33) . 64
Similarly, γHV68 infection drives upregulation of host pol III-dependent short-interspersed nuclear element 65 (SINE) RNAs, which in turn, mediate increased viral gene expression (34, 35) . Additionally, our lab has reported 66 that reactivation of a latently-infected γHV68 cell line results in increased expression of TMERs within a rare 67 subset of the population (36) . Notably, dysregulation of pol III is a common feature of many cancer cells, 68 implicating γHV infection-driven alteration of pol III activity as one potential contributor to γHV-associated 69 malignancies (37). Therefore, understanding how γHV infection alters pol III activity is integral to elucidating 70 mechanisms of γHV pathogenesis. 71
Due to the importance of γHV ncRNAs during infection and the unique transcriptional regulation afforded 72 by RNA pol III, the overall objective of this study was to characterize the activity of host and viral pol III-dependent 73 promoters during lytic γHV68 infection. To this end, we used a luciferase-reporter system optimized to report pol 74
III-dependent transcriptional activity to investigate how virus infection regulated pol III promoter activity in vitro. 75
We found that γHV68 infection upregulates the activity of multiple viral and host pol III promoters, a process 76 further associated with the induction of pol III-dependent targets. These studies indicate that lytic γHV infection 77 can broadly enhance RNA pol III promoter activity to modify the ncRNA landscape of infected cells. 78 γHV68 infection activates pol III-dependent promoters 5
RESULTS

79
RNA polymerase III can transcribe RNA from a variety of gene-internal (type 1 and 2) and gene-80 external (type 3) promoters ( Fig 1A) . These promoters contain distinct motifs that determine which transcription 81 factors bind to the promoter to recruit pol III (38). To understand how HV lytic replication influenced RNA pol 82 III promoter activity without the confounding factors of RNA sequence or stability, we sought to study a series 83 of viral and host pol III promoters using a luciferase assay system previously used to study pol III promoter 84 activity (39). Several host and viral pol III promoters encompassing a variety of promoter types and motifs were 85 selected for analysis (Supplemental Figure 1 ). Pol III promoters included host (U6, tRNA-Tyr, and vault RNA 1-86 1) and viral promoters (γHV68 TMER1, TMER4, TMER5; EBV EBER1 and EBER2; and adenovirus VA1). A 87 subset of studies further compared promoter variants, encompassing either the minimal promoter elements 88 ("minimal") or including additional accessory sequences ("full"). See Supplemental Figure 1 for promoter 89 schematics, and Table 1 for a list of all promoters examined. 90
To analyze the activity of pol III promoters by luciferase assay, we selected the reporter plasmid pNL1.1 91 (Promega), as the NanoLuc luciferase in this reporter creates a brighter signal and the protein is smaller than 92 its Renilla and Firefly counterparts; the smaller protein size is more consistent with pol III processivity of small 93 ncRNAs. Our analysis of the pNL1.1 sequence revealed a pol III termination signal within the luciferase coding 94 gene (TTTT). Therefore, to examine the activity of pol III promoters without the potential for early termination, 95
we introduced silent mutations into the NanoLuc reporter construct to remove the termination signal. This new 96 vector was named "pNLP3" to reflect that it is a NanoLuc reporter optimized for pol III (Fig 1B) . The human U6 97 promoter was cloned into both pNL1.1 and pNLP3 to compare the effects of removing the pol III termination 98 signal, with promoter activity measured 24 hours post-infection. We found that removal of the termination 99 signal increased the luciferase output, indicating that there was more read-through of the full NanoLuc gene 100 from pNLP3 ( Fig 1B) . Furthermore, RT-PCR analysis of the NanoLuc transcript transcribed from the U6 101 promoter in either the pNL1.1 or pNLP3 vector revealed more full-length NanoLuc transcript from the pNLP3 102 vector ( Fig 1C) . This indicates that the pNLP3 vector allows for optimal pol III transcription of the reporter gene. 103
We therefore used the pNLP3 vector as the backbone for analysis of all other pol III promoters included in this 104
study. 105
With an optimized pol III reporter construct, we assessed how different pol III promoters respond to 106 γHV68 infection over time. We first compared the activity of the human U6 (type 3) and γHV68 TMER1 (type 2) 107 promoters. HEK 293 cells were transfected with pNLP3 vectors containing either the U6 or TMER1 promoter, 108 co-transfected with an SV40 (pol II promoter)-driven Firefly luciferase vector, then infected with γHV68 ( Fig  109   2A ). Cell lysates were collected every 4 hours for 24 hours post-infection to quantify promoter activity as 110 defined by NanoLuc luciferase activity. This analysis revealed that HV68 infection resulted in a time-111 dependent increase in NanoLuc activity for both the U6 and TMER1 promoters (left panel, Fig 2B-2C) relative 112 γHV68 infection activates pol III-dependent promoters 6 to mock-infected samples. HV68 infection also resulted in a time-dependent increase in expression of the 113 control, Firefly luciferase reporter (second panel from left, Fig 2B-2C) . The results for dual luciferase assays 114 are typically reported as relative luminescence units (RLUs), where the reporter luminescence units (LUs) are 115 normalized to the luminescence units of the control luciferase (i.e., NanoLuc LUs / Firefly LUs). However, since 116 γHV68 infection simultaneously increased luminescence from both the NanoLuc reporter, and from the control 117
Firefly reporter, this normalization errantly implied decreased relative U6 promoter activity with infection ( Fig  118   2B ). Given the limitation of standardizing pol III promoter activity relative to a pol II promoter control (i.e. SV40 119 promoter), all subsequent analyses report promoter activity as a fold change in NanoLuc luminescence 120 comparing mock and HV68 infected samples. We found that the U6 promoter drives high basal luciferase 121 activity under mock conditions (left panel, Fig 2B) , with a further increase in raw and normalized U6-expressed 122 NanoLuc LUs throughout infection ( Fig 2B) . In contrast, the TMER1 promoter was characterized by extremely 123 low basal luciferase activity (left panel, Fig 2C) in mock conditions; however, this promoter was strongly 124 induced by infection ( Fig 2C) . These data suggest that γHV68 lytic infection increases the activity of multiple 125 pol III promoter types, with a more robust induction of the type 2 promoter of TMER1 compared to the U6 126
promoter. 127
We further analyzed the activity of several other promoter types to assess how they are regulated 128 during γHV68 infection. Experiments indicated that HV68 infection induced activity from multiple pol III 129 promoters, including the human U6 and tRNA-Tyr promoters, the EBER1 and EBER2 promoters, and TMER1, 130 4, and 5 promoters (Fig 3) . Though the vaultRNA1-1 promoter was cloned into the reporter, there was no 131 detectable activity from this construct (unpublished data). These promoters have different levels of baseline 132 NanoLuc luciferase activity under mock conditions, with the U6 and EBER promoters showing high activity, 133 and the TMER promoter displaying minimal detectable activity under mock conditions (unpublished data). Of 134 the promoters tested, the TMER promoters consistently showed the greatest induction of luciferase activity 135 during infection. 136
We compared the sequences of TMER promoters to identify which features of these promoters could 137 potentially contribute to the strong induction of activity during infection. The TMER promoters initially analyzed 138 contained the TMER promoter, as well as extended sequence around the minimal promoter elements (see 139 Supplementary Figure 1 for diagrams). Considering that the extra sequence included in these "full" promoters 140 may contribute to infection-induced activity, we created a panel of "minimal" TMER promoters that contain only 141 the sequence canonically identified as the minimal promoter elements necessary for transcription, i.e. the 142 sequence beginning from the A box to the end of the B box (Supplemental Figure 1 ). Additionally, we removed 143 the upstream sequence from the EBER promoters; these EBER minimal promoters were used to further 144 analyze how extended sequences can alter promoter induction during infection. As previously described, these 145 constructs were transfected into HEK 293 cells, then infected with γHV68. The fold change in NanoLuc activity 146 relative to mock-treated samples was compared after 24 h of infection (Fig 4) . When we compared the relative 147 inducibility of EBER "full" versus "minimal" promoters, "minimal" promoters showed greater virus-inducibility. 148
This enhanced inducibility of the "minimal" EBER promoters likely reflects the reduced baseline luminescence 149 from these promoters (unpublished data). Conversely, TMER minimal promoters displayed a weaker induction 150 during infection than their "full" counterparts, suggesting the sequence surrounded the TMER minimal 151 promoters drives stronger expression during infection. These results indicate that the sequence surrounding 152 minimal pol III promoter elements impacts both the baseline activity and inducibility of these promoters during 153
infection. 154
Luciferase readouts of pol III promoter activity allowed us to uniformly analyze pol III promoter activity. 155
This assay does not directly measure the level of RNAs, however, instead relying on an enzymatic readout of 156 luciferase protein activity. To ensure that HV68 infection was inducing pol III activity transcriptionally, we used 157 the same NanoLuc constructs to measure promoter activity at the RNA level by performing RT-qPCR for the 158 NanoLuc transcript. Following the same protocol as used for the luciferase assays, HEK 293 cells were 159 transfected with pGL3 and the pNLP3 vector expressed by pol III promoters of interest (as outlined in Fig 2) . 160
Cells were then infected with γHV68 and RNA was purified from cells 16 or 24 h post-infection. Primers 161 targeting the NanoLuc gene were used for qPCR following reverse transcription of the RNA. Infection 162 increased the NanoLuc RNA expression from the U6 and TMER1 promoters, with more modest induction from 163 the EBER promoters ( Fig 5A) . These results indicate that HV68 infection stimulates pol III-promoter activity 164 from multiple host and viral promoters, measured at both the transcriptional and translational level. To extend 165 these findings, we further measured NanoLuc RNA expression from "minimal" or "full" TMER promoters. These 166 studies demonstrated the HV68 infection increased NanoLuc RNA from the "minimal" promoter relative to 167 mock infected samples, with further RNA induction from the "full" TMER promoter. These results strongly 168 suggest that the NanoLuc reporter assay serves as a faithful readout for pol III-dependent transcription, 169 quantified at both the RNA and protein level. These findings also emphasize that sequences outside of the 170 minimal TMER promoters contribute to increased expression during infection. 171
HV lytic replication critically depends on viral DNA replication and late gene transcription, processes 172 that are inhibited by phosphonoacetic acid (PAA) (40, 41). We therefore tested the impact of PAA on virus-173 induced pol III induction. To do this, HEK 293 cells were transfected with pNLP3-TMER1 and infected as 174 before, with one set of samples receiving PAA treatment (200μg/mL) after 1 h of viral inoculation. RNA was 175 isolated 16 h post-infection and RT-qPCR was performed to detect the NanoLuc transcript. Notably, treatment 176 with PAA during infection had no impact on the induction of NanoLuc RNA compared to HV68 infected cells, 177
indicating that viral DNA replication and late gene synthesis was not required for pol III induction ( Fig 6A) . 178
Though PAA treatment had no effect on the level of NanoLuc RNA levels (i.e. transcription), PAA treatment 179 was consistently associated with increase luciferase enzymatic activity, with PAA-treated HV68-infected 180 γHV68 infection activates pol III-dependent promoters 8 cultures characterized by a greater apparent induction of luciferase activity compared to HV68-infected 181 cultures alone. This PAA-driven enhancement of luciferase activity was observed for multiple pol III promoters, 182 including U6, TMER1, 4 and 5 and EBER 1 and 2 ( Fig 6B) . The increase in luciferase activity following PAA 183 treatment, with minimal impact on NanoLuc RNA, strongly suggests that PAA treatment enhanced the 184 translational output from the promoters tested. These data suggest that viral late gene expression plays an 185 additional role in translation that is not seen at the transcriptional level, a phenomenon independent of pol III 186 promoter activity. 187
Given the reported relationship between the NF-κB pathway and the expression of pol III-dependent 188 transcripts (31), we analyzed the effect of NF-κB activation or inhibition on the activity of the U6 and TMER1 189 promoters via luciferase activity. First, we measured induction of an NF-κB reporter plasmid following treatment 190 with either TNF, a known inducer of the NF-κB pathway, or following HV68 infection. Whereas TNF 191 induced NF-κB reporter activity at 4 and 24 hours post-treatment, HV68 infection had no measurable impact 192 on expression from the NF-κB reporter (Supplemental Figure 2A ). Next, we analyzed the impact of NF-κB 193 manipulation on pol III promoter activity. Treating cells with TNF modestly increased U6 promoter activity, 194 albeit to a lesser extent than HV68 infection (Supplemental Figure 2B ). TMER1 promoter activity was not 195 affected by TNFα treatment. Inhibition of NF-κB with the BAY 11-7082 (BAY 11) compound increased U6-196 expressed luciferase activity in virus infected conditions, yet had no significant impact on TMER1 promoter 197 activity after infection (Supplemental Figure 2C ). This indicates a potential role of NF-κB in inhibiting pol III 198 promoter activity during infection; however, this effect is only observed in the case of a gene-external (i.e. type 199
3) promoter. Ultimately, these data do not support a significant role of the NF-κB pathway in the observed 200 induction of pol III promoter activity after HV68 infection. 201
While our analysis of pol III promoter activity suggested a general induction during infection, a previous 202 report suggested that only a subset of host pol III-transcribed genesthe SINE RNAsare increased during 203 lytic γHV68 infection (34). These studies were largely based on analysis of total RNA of infected cells. To gain 204 further insight into endogenous host ncRNA expression during lytic γHV68 infection, we made use of the 205 PrimeFlow Assay kit, which allows for flow cytometry-based quantitation of RNA expression at the single-cell 206 level. Murine fibroblast cells (3T12) were mock-treated, infected with wild-type (WT) HV68, or infected with an 207 EBER-knock in (EBER-KI.HV68) recombinant HV68 that lacks the TMERs and instead contains insertion of 208 the EBV EBERs into the TMER locus. EBER-KI.HV68 was competent for viral replication (manuscript in 209 progress). 3T12 cells were infected with an MOI of 1 and harvested at 16 h post-infection, conditions that result 210 in a mixed population of virally infected and uninfected cells. Cells were then queried with fluorescent probes to 211 detect viral gene expression as defined by either the HV68 TMERs or the EBV EBERs, expressed from the 212 context of the HV68 genome. Host ncRNA for U6 snRNA or 4.5 rRNA (the murine equivalent of human 5S 213 γHV68 infection activates pol III-dependent promoters 9 rRNA) expression was then assessed, comparing expression between cells with virus expression (i.e. TMER+ 214 or EBER+) and cells lacking virus expression (i.e. TMER-or EBER-). Gating schemes and probe specificity are 215 shown in Supplemental Figure 3 . Notably, probes for the TMERs and EBERs were specific for their intended 216 targets, with no detectable TMER or EBER expression in mock-infected samples, TMER+ cells only present in 217 WT HV68 infected samples, and EBER+ cells only present in EBER-KI.HV68 infected samples. We next 218 compared the relative expression of the U6 (Fig 7A-B) and 4.5S ncRNAs ( Fig 7C-D) between cells with active 219 viral RNA expression versus those cells that did not express these viral ncRNAs. Analysis of the geometric 220 mean fluorescence intensity (gMFI) for the U6 snRNA and 4.5 rRNA probes revealed increased expression of 221 U6 and 4.5 rRNA ncRNAs in virally infected cells (i.e. TMER+ or EBER+) compared to uninfected cells (TMER-222 or EBER-) ( Fig 7E-F) . These data demonstrate an increase in host pol III-transcribed ncRNAs in γHV68-223 infected cells and emphasize the benefit of single cell analysis of endogenous RNA expression to quantify 224 ncRNA expression during virus infection. While γHV infection is known to alter expression of host genes, and viral ncRNAs are integral for 227 pathogenesis, the transcriptional regulation of these ncRNAs has remained unclear. Here, we propose that 228 different pol III promoter types allow for distinct means for transcriptional regulation during infection. This study 229 focused on the impact of γHV68 lytic replication on pol III promoter activity, identifying that lytic infection drives 230 a general upregulation of promoter activity across multiple host and viral pol III-dependent transcripts. This 231 upregulation was measured by a luciferase assay optimized for pol III transcription, with increased pol III-232 dependent promoter activity quantified by luciferase activity and RNA expression, with complementary findings 233 revealed through the use of flow cytometric analysis of ncRNA expression. These findings emphasize the utility 234 of the modified NanoLuc luciferase system to analyze pol III promoter activity, and provide clear evidence for 235 pol III promoters with large differences in basal and inducible promoter activity. They further emphasize the 236 capacity of HV lytic infection to modify pol III-dependent transcriptional machinery in infected cells, a process 237 that likely facilitates productive virus replication (34). At this time, it remains unknown whether pol III machinery 238 or transcription is altered during γHV68 latent infection or reactivation from latency. 239
Our use of a luciferase reporter to measure the activity of pol III promoters allowed us to directly 240 compare the functional activity of multiple pol III promoters, while avoiding potential differences that may arise 241 due to ncRNA sequence, structure, or stability. Though pol III promoters conventionally drive expression of 242 non-coding RNAs, there is clear precedent that pol III can transcribe translation-competent RNA (42, 43), and 243 luciferase reporters have been used for high throughput and unbiased analysis of pol III promoter activity (44, 244 45) . Inspired by these studies, we cloned several host and viral ncRNA promoters into a NanoLuc luciferase 245 reporter to measure their activity during lytic γHV68 infection. We chose the NanoLuc luciferase as our To 246 further enhance the robustness of this reporter, we identified and removed a pol III termination sequence within 247 the NanoLuc gene which approximately doubled luciferase reporter activity. Though pol III transcription should 248 theoretically be terminated in the original NanoLuc reporter, pol III read-through of termination signals has 249 been reported (46) . In total, use of the modified NanoLuc reporter construct afforded a sensitive and robust 250 readout for assessing pol III promoter activity. 251
Through use of this pol III reporter assay, we found that HV68 infection increased promoter activity 252 across a range of host and viral pol III promoters. This suggests that γHV68 infection generally upregulates pol 253 III activity. Interestingly, the consequence/magnitude of induction elicited by infection varied between 254 promoters. For example, the U6 promoter conveyed high basal activity with infection resulting in a modest 255 induction of U6 promoter activity. Conversely, the TMER promoters exhibited extremely low basal activity in 256 mock-infected conditions, with dramatic induction after HV68 infection. The inducibility of the TMERs was 257 further enhanced by accessory sequences outside of the minimal A and B box elements. One explanation for 258 this enhanced induction is that these extended sequences may contain additional transcriptional elements that 259 are integral to the promoter itself. While formally possible, it is notable that accessory sequences across the 260
TMERs are not conserved (Supplemental Fig 4A) . An alternate explanation for the enhanced activity of the full 261 TMER promoters is that inclusion of the extended sequence includes the full tRNA-like structure of the TMER 262 genes (Supplemental Fig 4B) . It is interesting to speculate that this tRNA-like structure could either lend 263 greater stability to transcripts, or protect the transcripts from degradation by host exonucleases or the viral 264 endonuclease, muSOX (47). Although pol III transcription is frequently associated with the transcription of 265 housekeeping ncRNAs, there is clear precedent that pol III can also participate in inducible gene expression 266 (e.g. HV68-induced expression of SINEs) (34, 35) . Whether the TMERs have conserved regulatory 267 mechanisms with host inducible ncRNAs is currently unknown, however, the TMERs share more promoter 268 similarity to the SINEs (type 2, gene internal) than to the vault RNAs (type 3, gene external). 269
Our studies demonstrated that infection increased NanoLuc expression at both the RNA and protein 270 level, indicating that virus infection increased pol III promoter activity and not some secondary measurement. 271
This induction was further associated with increased expression of the host ncRNAs U6 and 4.5 rRNA. While 272 these findings emphasize the impact that infection has on pol III-dependent transcription, our studies did reveal 273 one context in which infection impacted a post-transcriptional measurement. Unexpectedly, inhibition of viral 274 late gene expression with PAA resulted in increased luciferase activity from nearly all of the promoters 275 examinedthis phenomenon was only seen at the level of NanoLuc protein activity, not at the level of 276 NanoLuc RNA. The ability of PAA to enhance NanoLuc protein activity, with no commensurate change in RNA 277 expression, suggests that viral late genes may have a possible role in tempering translation. Manipulation of 278 host translational machinery by the herpesviruses is a common strategy that is required for optimal virus 279 replication and the production of virus progeny (48). 280
Previous reports show that γHV infection can have diverse effects on pol III transcription, ranging from 281 a general induction of pol III machinery (e.g. in the context of EBV and EBNA1 (33, 49), to the selective 282 induction of pol III-transcribed RNAs (e.g. induction of specific host vaultRNAs in EBV latently infected cells 283 (31, 32), and the host SINE RNAs in γHV68-infected cells (34)). One challenge in interpreting these different 284 findings is that these studies have been done in different states of infection (latent versus lytic), in different cell 285 types, and in different states of cellular transformation. In many cases, the mechanistic insights gained from 286 these studies could only be gained through the use of in vitro studies. Future studies will benefit from direct 287 comparisons of primary virus infection, when possible, coupled with the analysis of endogenous ncRNA 288 expression. In keeping with this, we anticipate that the HV68 system will afford unique insights in how the 289 HVs regulate pol III-dependent ncRNA expression, allowing the analysis of primary infection coupled with 290 technologies to measure endogenous ncRNA expression. For example, our single-cell analysis of pol III-291 derived transcripts -U6 snRNA and 4.5 rRNAsupported that γHV68-infection not only increases pol III-292 dependent promoter activity, but also increases the endogenous expression of these transcripts. How host and 293 viral ncRNAs are regulated as a function of cell type and virus stage of infection remains an important 294 unanswered question. 295
In total, our studies revealed a γHV68-dependent induction in the activity of host and viral pol III 296 promoters. This induction was seen in the expression of a reporter gene, as well as in the endogenous 297 expression of pol III-dependent transcripts. Though previous reports have focused on the virus-mediated 298 upregulation of specific host ncRNAs, these experiments suggest a broader effect of lytic γHV68 infection on 299 pol III activity. This suggests that γHV68 modulation of the host transcriptional landscape goes beyond mRNA 300 regulation, and that pol III-dependent transcripts are likely to play a wider role in γHV68 pathogenesis than 301 previously appreciated. 302 γHV68 infection activates pol III-dependent promoters
13
METHODS 303
Viruses and tissue culture. All viruses were derived from a BAC-derived WT γHV68 (50 Koszinowski 304 UH. 2000) For some experiments, the TMER total knock-out (TMER-TKO) virus was used; this virus was 305 generated as previously described (26). Viruses were propagated and titered as previously described (26). 306 EBER-KI virus contains EBERs 1 and 2 in the TMER-TKO virus backbone. Its generation and characterization 307 are described in a manuscript in preparation. 308
Human endothelial kidney (HEK 293) and murine fibroblast (3T12) cells were cultured in Dulbecco's 309 modified Eagle medium (DMEM; Life Technologies) supplemented with 5% fetal bovine serum (FBS; Atlanta 310 Biologicals), 2 mM L-glutamine, 10 U/ml penicillin, and 10 μg/ml streptomycin sulfate (complete DMEM). Cells 311 were cultured at 37 o C with 5% CO2. 312
Mutagenesis of pNL1.1 to create the pNLP3 NanoLuc luciferase reporter. The promoterless 313
NanoLuc luciferase reporter vector pNL1.1[Nluc] was obtained from Promega, and primers were designed to 314 introduce silent mutations to remove the pol III termination signal in the NanoLuc coding sequence; these 315 primers are listed in Supplementary Table 1 . Mutagenesis PCR was performed with the following cycles: (i) 95° 316 for 30s, (ii) 12 cycles of 95°C for 30s, 55°C for 1 min, 68°C for 3 m. The resulting DNA was digested with DpnI 317 (New England Biolabs Inc) and transformed into XL1-Blue super-competent cells (Agilent). Bacterial colonies 318 were sequenced to confirm the correct mutations. The resulting plasmid was named "pNLP3" to indicate that it 319 is a NanoLuc plasmid optimized for pol III. 320
Generating a pol III promoter-driven NanoLuc reporter panel. All promoters were generated to 321 include XhoI and HindIII overhang sequences on the 5' and 3' ends respectively. Several promoters were 322 constructed using ligated oligonucleotides. PCR-amplified promoters and pNLP3 were digested with XhoI and 323
HindIII, then promoters were ligated into pNLP3 using T4 DNA ligase (New England BioLabs Inc). See 324 Supplementary Table 1 for primers used to PCR-amplify promoters. Ligated constructs were transformed into 325 One Shot electro-or chemically competent TOP10 E. coli cells (Thermo Fisher Scientific, #C404052 or 326 #C404010), which were then plated at several dilutions on LB agar containing ampicillin. Resulting colonies 327 were expanded in LB broth with ampicillin and plasmid was isolated using the QIAprep Spin Miniprep Kit 328 (Qiagen). All constructs were confirmed by sequencing. 329
Transfecting cells. For transfections, HEK 293 cells were cultured in 5% FBS DMEM without penicillin 330 or streptomycin for approximately 24 hours. Transfection solutions contained Opti-MEM (Thermo Fisher 331 Scientific), NanoLuc plasmid (pNLP3 with inserted pol III promoters), and the Firefly control plasmid (pGL3-332
Control; Promega). After plasmids were added to the Opti-MEM, solutions were incubated with X-tremeGENE 333 HP DNA Transfection Reagent (Sigma-Aldrich) for at least 15 minutes at room temperature. Transfections 334 were performed in several plate formats, depending on the downstream use; transfection solutions were added 335 dropwise to the appropriate wells (10uL of solution for 96-well plate, 100uL of solution in 12-well plates, 200uL 336 of solution in 6-well plates). For all transfections, the molar ratio of NanoLuc plasmid to Firefly plasmid was 337 kept at 10:1; the total amount of DNA transfected per well was adjusted depending on the plate size 338 (approximately 10ng for 96-well, 100ng for 12-well, and 200ng for 6-well). Cells were incubated with 339 transfection solution for 24 hours prior to downstream applications, unless otherwise stated. 340
To analyze how promoter activity was affected by γHV68 infection, transfected HEK 293 cells were 341 infected with WT, TMER-TKO, or EBER-KI γHV68 at a multiplicity of infection (MOI) of 1 plaque forming unit 342 per cell. Cells were cultured for approximately 24 h prior to infection. Cell counts were determined by treating 343 with 0.05% Trypsin-EDTA (Life Tech, #25300-054) to remove and cells. These cells were mixed with Trypan 344
Blue dye (Bio-Rad, #145-0021) to obtain a live cell count using the TC20 Automated Cell Counter (Bio-Rad). 345
Virus stocks were mixed with 5% complete DMEM, then added to cells and incubated with virus for 1 hour. (Qiagen, #201205) with the following conditions: (i) 95⁰C for 5 min, (ii) 40 cycles of 94⁰C for 30 s, 52⁰C for 30 s, 368 72⁰C for 30 s, (iii) 72⁰C for 10 m, (iv) hold at 4⁰C. RNA samples that showed no product following PCR 369 amplification were deemed DNA-free, and converted to cDNA using SuperScript III Reverse Transcriptase 370 γHV68 infection activates pol III-dependent promoters 15 (Invitrogen, #18080093) following the manufacturer's protocol. 100ng of the cDNA was then used for qPCR 371 analysis of the NanoLuc and 18S genes using the iQ TM SYBER® Green Supermix (Bio-Rad, #1708880) with the 372 following conditions: i) 95°C for 3 m, ii) 40 cycles of 95°C for 15 s, 60°C for 1 m, iii) 95°C for 15 s, 60°C for 1 m, 373 95°C for 15 s. Amplification of NanoLuc was normalized to 18S expression to calculate the relative difference of 374 NanoLuc expression using the Pfaffl method: PrimeFlow RNA assay. The PrimeFlow RNA assay kit (Thermo Fisher Scientific, # 88-18005-210) was 376 used to analyze the endogenous expression of non-coding RNAs in mock and HV68-infected 3T12 cells. Cells 377 were infected at an MOI of 1 for 16 h, then processed with the PrimeFlow kit following the manufacturer's 378 protocol. Cells were treated with probes for TMERs (Type 4/AF488), EBERs (Type 1/AF647), and U6 snRNA or 379 4.5 rRNA (Type 6/AF750). Samples were collected on an LSR II Flow Cytometer (BD Biosciences), and included 380 single stain and "full minus one" controls. Flow cytometry data were analyzed using FlowJo software (version 381 10.6.1), with compensation based on single stained beads and cells. Compensated flow cytometry data were 382 subsequently analyzed for singlet events (based on doublet discrimination), with positive and negative 383 populations based on control samples. 384
Software and statistical analysis. Statistical analysis and graphing were done in GraphPad Prism 385 (Version 8.0d). Statistical significance was tested by unpaired t test (comparing two conditions) or one-way 386 ANOVA (comparing three or more conditions) and subjected to multiple corrections tests using recommended 387 settings in Prism. All flow cytometry data were analyzed in FlowJo (version 10.6.1) with flow cytometry data 388
shown as pseudo-color dot plots. 389
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We thank the members of the Clambey and van Dyk lab for helpful discussions, members of the Colorado 393 RNA Bioscience Initiative for their insights, the Colorado ClinImmune core for flow cytometry services and the 394 Genomics Shared Resource of the University of Colorado Cancer Center which receives direct funding support 395 from the National Cancer Institute through Cancer Center Support Grant P30CA046934. 396 Optimization of the NanoLuc reporter vector. Mutations were introduced into the pNL1.1 vector to remove the 541 pol III termination signal (TTTT) from the Nanoluc coding region, resulting in the pNLP3 vector. The human U6 542 promoter was cloned into each of these reporters, and dual luciferase assays were performed to compare 543 luciferase output. Data shown is representative of two independent experiments with biological triplicates. 544
FIGURE LEGENDS 531
Additionally, RNA was isolated from cells transfected with these two constructs. Cells were mock or WT γHV68-545 infected for 16 h, then cellular RNA was used as a template for primers targeting the entire NanoLuc gene (top 546 gel, 534 nt), or targeting just the NanoLuc sequence upstream of the termination sequence (bottom gel, 234 nt). were treated as previously described and RNA was purified from cells at 16 h post-infection (U6 n = 2, TMER1, 585 n = 5) or 24hpi (EBER1 n = 1, EBER2 n = 1, TMER4 n = 2, and TMER5, n = 1). RNA was converted to cDNA, 586 then LightCycler real-time PCR using Syber Green was performed with primers targeting the NanoLuc gene and 587 a host control gene (18S). The relative difference of NanoLuc was calculated using the Pfaffl method (2001, 588 
